The Board has reopened the Veteran's claim of service connection for membranous nephropathy and finds that new and material evidence has been received to support this claim. The condition is now considered secondary to service-connected hypertension.
The deciding factor: New medical opinions indicate a possible relationship between the Veteran's membranous nephropathy and his service-connected hypertension, which supports reopening of the claim.
- Claimed conditions
- membranous nephropathy
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- August 20, 2015
- Citation
- 1535622
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 1535622.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
Service connection for scleroderma as secondary to service-connected membranous nephropathy is granted with a rating of 60% effective May 20, 2014.
- Whole decision: Granted
The Board has granted service connection for the Veteran's kidney condition, including nephrotic syndrome and idiopathic glomerulonephritis, finding that his condition was incurred during service or is otherwise related to active-duty service.
- Whole decision: Granted
The Board has determined that the Veteran's chronic kidney disease is proximately due to his service-connected prostate cancer, and thus grants service connection for this condition.
- Whole decision: Remanded (sent back)
The Board has determined that the January 2017 VA examinations for membranous nephropathy and dermatophytosis were inadequate, and thus remanded these issues to allow for further adjudication.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.